Published in Blood Weekly, March 9th, 2006
Scientists in Spain conducted a study "to assess the usefulness of [F-18]fluorodeoxyglucose positron emission tomography in the detection of bone marrow involvement in malignant lymphoma and its impact in clinical management. One hundred and six consecutive patients with a confirmed diagnosis of lymphoma, referred for staging or restaging of Hodgkin's lymphoma (n=18) or non-Hodgkin's lymphoma (n=88), were reviewed retrospectively."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.